Literature DB >> 2555544

Phosphorylation sites of the E2 transcriptional regulatory proteins of bovine papillomavirus type 1.

A A McBride1, J B Bolen, P M Howley.   

Abstract

The E2 open reading frame of bovine papillomavirus type 1 (BPV-1) encodes three transcriptional regulatory proteins. The full-length open reading frame encodes a protein of 410 amino acids which functions as a transcriptional transactivator. Two transcriptional repressor proteins, E2-TR and E8/E2, contain the C-terminal 249 and 204 amino acids, respectively. We have expressed both the full-length E2 protein and the E2-TR repressor protein in insect cells, by using recombinant baculoviruses, and in mammalian COS-1 cells, by using a chimeric simian virus 40/BPV-1 virus. Analysis of the E2 proteins revealed that both the transactivator and repressor forms are phosphorylated predominately on serine residues at similar sites in both expression systems. By a combination of peptide mapping and site-directed mutagenesis techniques, the serine residues at positions 298 and 301 were determined to be the major phosphorylation sites of the BPV-1 E2 proteins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2555544      PMCID: PMC251169          DOI: 10.1128/JVI.63.12.5076-5085.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  A lymphocyte-specific protein-tyrosine kinase gene is rearranged and overexpressed in the murine T cell lymphoma LSTRA.

Authors:  J D Marth; R Peet; E G Krebs; R M Perlmutter
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Transactivation of a bovine papilloma virus transcriptional regulatory element by the E2 gene product.

Authors:  B A Spalholz; Y C Yang; P M Howley
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

4.  Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis.

Authors:  S Rogers; R Wells; M Rechsteiner
Journal:  Science       Date:  1986-10-17       Impact factor: 47.728

5.  Virus-specific transcription in bovine papillomavirus-transformed mouse cells.

Authors:  C A Heilman; L Engel; D R Lowy; P M Howley
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

6.  Production of human c-myc protein in insect cells infected with a baculovirus expression vector.

Authors:  C Miyamoto; G E Smith; J Farrell-Towt; R Chizzonite; M D Summers; G Ju
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

7.  In vitro association and phosphorylation of polyoma virus middle T antigen by cellular tyrosyl kinase activity.

Authors:  J B Bolen; M A Israel
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

8.  Modification and secretion of human interleukin 2 produced in insect cells by a baculovirus expression vector.

Authors:  G E Smith; G Ju; B L Ericson; J Moschera; H W Lahm; R Chizzonite; M D Summers
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Production of human beta interferon in insect cells infected with a baculovirus expression vector.

Authors:  G E Smith; M D Summers; M J Fraser
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

10.  A dimer of BPV-1 E2 containing a protease resistant core interacts with its DNA target.

Authors:  N Dostatni; F Thierry; M Yaniv
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

View more
  38 in total

1.  Formation of the complex of bovine papillomavirus E1 and E2 proteins is modulated by E2 phosphorylation and depends upon sequences within the carboxyl terminus of E1.

Authors:  M Lusky; E Fontane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-15       Impact factor: 11.205

2.  Brd4-independent transcriptional repression function of the papillomavirus e2 proteins.

Authors:  Michal-Ruth Schweiger; Matthias Ottinger; Jianxin You; Peter M Howley
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

Review 3.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

4.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

5.  Phosphorylation of the avian retrovirus integration protein and proteolytic processing of its carboxyl terminus.

Authors:  R Horton; S R Mumm; D P Grandgenett
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

6.  The 68-kilodalton E1 protein of bovine papillomavirus is a DNA binding phosphoprotein which associates with the E2 transcriptional activator in vitro.

Authors:  I L Blitz; L A Laimins
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

7.  Reconstitution of papillomavirus E2-mediated plasmid maintenance in Saccharomyces cerevisiae by the Brd4 bromodomain protein.

Authors:  Angela R Brannon; Julia A Maresca; Jef D Boeke; Munira A Basrai; Alison A McBride
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

8.  Transcriptional and replicational activation functions in the bovine papillomavirus type 1 E2 protein are encoded by different structural determinants.

Authors:  A Abroi; R Kurg; M Ustav
Journal:  J Virol       Date:  1996-09       Impact factor: 5.103

9.  Transient viral DNA replication and repression of viral transcription are supported by the C-terminal domain of the bovine papillomavirus type 1 E1 protein.

Authors:  M C Ferran; A A McBride
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

10.  Kinetic and equilibrium binding studies of the human papillomavirus type-16 transcription regulatory protein E2 interacting with core enhancer elements.

Authors:  C M Sanders; N J Maitland
Journal:  Nucleic Acids Res       Date:  1994-11-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.